Methamphetamine

doi:10.1017/CBO9780511543784.022

21 - Methamphetamine

from Part VI - Substance Abuse and Medications

Published online by Cambridge University Press: 06 January 2010

Liz Jacob and

Willam Haining III

Edited by

Daryl Fujii and

Iqbal Ahmed

Show author details

Liz Jacob: Affiliation:
University of Hawaii
Willam Haining III: Affiliation:
University of Hawaii
Daryl Fujii: Affiliation:
University of Hawaii, Manoa
Iqbal Ahmed: Affiliation:
University of Hawaii, Manoa

Book contents

Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Type: Chapter
Information: The Spectrum of Psychotic Disorders
Neurobiology, Etiology and Pathogenesis
, pp. 392 - 405

DOI: https://doi.org/10.1017/CBO9780511543784.022 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

Abi-Dargham, A. (2004). Do we still believe in the dopamine hypothesis? New data bring new evidence. International Journal of Neuropsychopharmacology, 7, S1–5.Google Scholar

American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders, 4th edn, Text Revision. Washington, DC: American Psychiatric Association.

Baumeister, A. A. & Francis, J. L. (2002). Historical development of the dopamine hypothesis of schizophrenia. Journal of the History of the Neurosciences, 11, 265–77.Google Scholar

Boutros, N. N. & Bowers, M. B. (1996). Chronic substance-induced psychotic disorders: State of the literature. Journal of Neuropsychiatry and Clinical Neuroscience, 8, 262–9.Google Scholar

Cass, W. A. & Manning, M. W. (1999). Recovery of presynaptic dopaminergic functioning in rats treated with neurotoxic doses of methamphetamine. Journal of Neuroscience, 19, 7653–60.Google Scholar

Caton, C. L., Drake, R. E., Hasin, D. S., et al. (2005). Differences between early-phase primary psychotic disorders with concurrent substance use and substance-induced psychoses. Archives of General Psychiatry, 62, 137–45.Google Scholar

Chang, L., Ernst, T., Speck, O., et al. (2002). Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users. Psychiatric Research Neuroimaging, 114, 65–79.Google Scholar

Chen, C. K., Lin, S. K., Sham, P. C., et al. (2003). Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis. Psychological Medicine, 33, 1407–14.Google Scholar

Community Epidemiology Work Group (2003). Epidemiologic Trends in Drug Abuse, Advance Report (NIH Publication No. 04–5363). Washington, DC: US Government Printing Office.

Drug Abuse Warning Network (2004, July). Amphetamine and Methamphetamine Emergency Department Visits, 1995–2002 (NIH Publication No. 02–4210). Washington, DC: US Government Printing Office.

Ernst, T., Chang, L., Leonido–Yee, M., & Speck, O. (2000). Evidence for long-term neurotoxicity associated with methamphetamine abuse: A 1H MRS study, Neurology, 54, 1344–9.Google Scholar

Flaum, M. & Schultz, S. K. (1996). When does amphetamine-induced psychosis become schizophrenia?American Journal of Psychiatry, 153, 812–15.Google Scholar

Fujii, D. (2002). Risk factors for treatment-resistive methamphetamine psychosis. Journal of Neuropsychiatry and Clinical Neurosciences, 14, 239–40.Google Scholar

Gonzalez, R., Rippeth, J. D., Carey, C. L., et al. (2004). Neurocognitive performance of methamphetamine users discordant for history of marijuana exposure. Drug and Alcohol Dependence, 76, 181–90.Google Scholar

Graham, A. W., Schultz, T. K., Mayo-Smith, M. F., Ries, R. K., Wilford, B. B. (eds.) (2003). Principles of Addiction Medicine, 3rd edn. Chevy Chase: American Society of Addiction Medicine.

Grant, I., Gonzalez, R., Carey, C., Natarajan, L., & Wolfson, T. (2003). Non-acute (residual) neurocognitive effects of cannabis use: A meta-analytic study. Journal of the International Neuropsychological Society, 9, 679–89.Google Scholar

Harvey, D. C., Lacan, G., Tanious, S. P., & Melega, W. P. (2000). Recovery from methamphetamine-induced long-term nigrostriatal dopaminergic deficits without substantia nigra cell loss. Brain Research, 871, 259–70.Google Scholar

Iwanami, A., Sugiyama, A., Kuroki, N., et al. (1994). Patients with methamphetamine psychosis admitted to a psychiatric hospital in Japan. Acta Psychiatrica Scandinavica, 89, 428–32.Google Scholar

Kalechstein, A. D., Newton, T. E., Longshore, D., et al. (2000). Psychiatric comorbidity of methamphetamine dependence in a forensic sample. Journal of Neuropsychiatry and Clinical Neurosciences, 12, 480–84.Google Scholar

Kalechstein, A. D., Newton, T. F., & Green, M. (2003). Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence. Journal of Neuropsychiatry and Clinical Neurosciences, 15, 215–20.Google Scholar

Ling, W. & Shoptaw, S. (1997). Integration of research in pharmacotherapy for substance abuse: Where are we? Where are we going?Journal of Addictive Disease, 16, 83–102.Google Scholar

Lowinson, J. H., Ruiz, P., Millman, R. B., Langrod, J. G. (eds.) (2005). Substance Abuse: A Comprehensive Textbook, Philadelphia, PA: Lippincott Williams & Wilkins.

Mikami, T., Naruse, N., Fukura, Y., et al. (2003). Determining vulnerability to schizophrenia in methamphetamine psychosis using exploratory eye movements. Psychiatry and Clinical Neurosciences, 57, 433–40.Google Scholar

National Drug Intelligence Center (2005). National Drug Assessment Report (DOJ Product No. 2005–Q0317–005). Washington, DC: Government Printing Office.

National Institute on Drug Abuse (2002). Research Report Series, Methamphetamine Abuse and Addiction (NIH Publication Number 02–4210). Washington, DC: Government Printing Office.

Nordahl, T. E., Salo, R., & Leamon, M. (2003). Neurocognitive effects of chronic methamphetamine use on neurotransmitters and cognition: A review. Journal of Neuropsychiatry and Clinical Neurosciences, 15, 317–25.Google Scholar

Paulus, M., Hozack, N., Frank, L., Brown, G. G., & Schuckit, M. A. (2003). Decision by methamphetamine-dependent subjects is associated with error-rate independent decrease in prefrontal and parietal activation. Biological Psychiatry, 53, 65–74.Google Scholar

Rawson, R. A., Gonzales, R., & Brethren, P. (2002). Treatment of methamphetamine use disorders: An update. Journal of Substance Abuse Treatment, 23, 145–50.Google Scholar

Rippeth, J. D., Heaton, R. K., Carey, C. L., et al. (2004). Methamphetamine dependence increases risk of neurocognitive impairment in HIV infected persons. Journal of International Neurocognitive Society, 10, 1–14.Google Scholar

Salo, R., Nordahl, T. E., Possin, K., et al. (2002). Preliminary evidence of reduced cognitive inhibition in methamphetamine-dependent individuals. Psychiatric Research, 111, 65–74.Google Scholar

Sato, M., Numachi, Y., & Hamamura, T. (1992). Relapse of paranoid psychotic state in methamphetamine model of schizophrenia. Schizophrenia Bulletin, 18, 115–22.Google Scholar

Seiden, L. S. & Sabol, K. E. (1996). Methamphetamine and methylenedioxymethamphetamine neurotoxicity: Possible mechanisms of cell destruction. Abstract. NIDAResearch Monographs, 163, 251–76.Google Scholar

Sekine, Y., Iyo, M., Ouchi, Y., et al. (2001). Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET. American Journal of Psychiatry, 158, 1206–14.Google Scholar

Shaner, A., Roberts, L. J., Eckman, T. A., et al. (1998). Psychiatric Services, 49, 684–90.

Sim, T., Simon, S. L., Domier, C. P., et al. (2002). Cognitive deficits among methamphetamine users with attention deficit hyperactivity disorder symptomatology. Journal of Addictive Diseases, 21, 75–89.Google Scholar

Simon, S. L., Domier, C., Carnell, J., et al. (2000). Cognitive impairment in individuals currently using methamphetamine. American Journal on Addictions, 9, 222–31.Google Scholar

Srisurapanont, M., Ali, R., Marsden, J., et al. (2003). Psychotic symptoms in methamphetamine psychotic inpatients. Journal of Neuropsychopharmacology, 6, 347–52.Google Scholar

Tomiyama, G. (1990). Chronic schizophrenia-like states in methamphetamine psychosis. Japanese Journal of Psychiatry, 44, 531–9.Google Scholar

Trites, R. L., Suh, M., Offord, D., Nieman, G., & Preston, D. (1976). Neuropsychologic psychosocial antecedents and chronic effects of prolonged use of solvents and methamphetamine. Psychiatric Journal of the University of Ottawa, 1(Suppl. 2), 14–20.Google Scholar

United States Drug Enforcement Agency (2005, February). State Factsheets: Hawaii 2005. Washington, DC: Government Printing Office.

Volkow, N. D., Chang, L., Wang, , , G., et al. (2001a). Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. Journal of Neuroscience, 21, 9414–18.Google Scholar

Volkow, N. D., Chang, L., Wang, , , G., et al. (2001b). Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. American Journal of Psychiatry, 158, 377–82.Google Scholar

Yeh, H. S., Lee, Y. C., Sun, H. J., & Wan, S. R. (2001). Six months follow-up of patients with methamphetamine psychosis. Chinese Medical Journal, 64, 388–94.Google Scholar

Yui, K., Goto, K., Ikemoto, S., et al. (1999). Neurobiologic basis of relapse prediction in stimulant-induced psychosis and schizophrenia: The role of sensitization. Molecular Psychiatry, 4, 512–23.Google Scholar

Yui, K., Goto, K., Ikemoto, S., et al. (2001). Susceptibility to subsequent episodes of spontaneous recurrence of methamphetamine psychosis. Drug and Alcohol Dependence, 64, 133–42.Google Scholar

Zweben, J. E., Cohen, J. B., Christian, D., et al. (2004). Psychiatric symptoms in methamphetamine users. American Journal on Addictions, 13, 181–90.Google Scholar